Table 7.
Univariate and Multivariate Analysis of Risk Factors Related to the Mortality of COVID-19 Patients without Underlying Diseases
| Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
| P value | OR | 95% CI | P value | |
| WBC | <0.001 | 0.502 | 0.032–7.881 | 0.624 |
| Lymphocytes | 0.001 | 0.008 | 0.000–4.208 | 0.130 |
| Neutrophils | <0.001 | 3.319 | 0.174–56.530 | 0.438 |
| CRP | 0.002 | 1.001 | 0.965–1.038 | 0.959 |
| TG/HDL-c ratio | 0.008 | 1.744 | 1.091–2.786 | 0.020 |
| LDL-c/HDL-c ratio | 0.112 | \ | \ | \ |
| TC/HDL-c ratio | 0.700 | \ | \ | \ |
Notes: P values indicate differences between survivor and non-survivor of COVID-19 patients without underlying diseases. P<0.05 was considered statistically significant (marked in bold).
Abbreviations: COVID-19, Coronavirus disease 2019; OR, odds ratio; CI, confidence interval; WBC, White blood cells; CRP, C-reactive proteins; TC/HDL-c ratio, total cholesterol-to-high-density lipoprotein cholesterol ratio; LDL-c/HDL-c ratio, low-density lipoprotein cholesterol-to-high-density lipoprotein cholesterol ratio; TG/HDL-c ratio, triglyceride-to-high-density lipoprotein cholesterol ratio.